Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (511-520 of 779) with videos related to

Pageof 78
Sort By:
Oncotarget|September 15, 2016
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinomaXiaoyan Ma, Hui Zhu, Hongbo Guo, et al.
Acta Cardiologica|January 23, 2009
Prevalence of and risk factors for peripheral arterial disease among Chinese hypertensive patients with and without known cardiovascular diseaseLiqiang Zheng, Jinming Yu, Jue Li, et al.
Oncotarget|November 9, 2016
Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusionDawei Chen, Xinyu Song, Fang Shi, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2020
High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancerWang Jing, Shijiang Wang, Xiao Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2020
Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapyXuanzong Li, Dai Zhang, Butuo Li, et al.
Oncotargets and Therapy|October 13, 2018
Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLCButuo Li, Cheng Li, Meiying Guo, et al.
Clinical Lung Cancer|March 5, 2015
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung CancerFen Zhao, Gang Ding, Wei Huang, et al.
Journal of Cardiothoracic Surgery|July 8, 2020
The feasibility of non-contrast enhanced plus contrast-enhanced computed tomography in discriminating invasive pure ground-glass opacity from pre-invasive pure ground-glass opacityShanshan Li, Jinming Yu, Xue Meng, et al.
Journal of Epidemiology|July 21, 2012
Prevalence of low ankle brachial index and its association with pulse pressure in an elderly Chinese population: a cross-sectional studyYiqiang Zhan, Jinming Yu, Ruoqing Chen, et al.
Oncotargets and Therapy|October 22, 2019
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective StudyNing An, Haoyi Wang, Ji Li, et al.
Pageof 78

Showing results (511-520 of 779) with videos related to

Sort By:
Pageof 78
Oncotarget|September 15, 2016
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinomaXiaoyan Ma, Hui Zhu, Hongbo Guo, et al.
Acta Cardiologica|January 23, 2009
Prevalence of and risk factors for peripheral arterial disease among Chinese hypertensive patients with and without known cardiovascular diseaseLiqiang Zheng, Jinming Yu, Jue Li, et al.
Oncotarget|November 9, 2016
Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusionDawei Chen, Xinyu Song, Fang Shi, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2020
High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancerWang Jing, Shijiang Wang, Xiao Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2020
Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapyXuanzong Li, Dai Zhang, Butuo Li, et al.
Oncotargets and Therapy|October 13, 2018
Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLCButuo Li, Cheng Li, Meiying Guo, et al.
Clinical Lung Cancer|March 5, 2015
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung CancerFen Zhao, Gang Ding, Wei Huang, et al.
Journal of Cardiothoracic Surgery|July 8, 2020
The feasibility of non-contrast enhanced plus contrast-enhanced computed tomography in discriminating invasive pure ground-glass opacity from pre-invasive pure ground-glass opacityShanshan Li, Jinming Yu, Xue Meng, et al.
Journal of Epidemiology|July 21, 2012
Prevalence of low ankle brachial index and its association with pulse pressure in an elderly Chinese population: a cross-sectional studyYiqiang Zhan, Jinming Yu, Ruoqing Chen, et al.
Oncotargets and Therapy|October 22, 2019
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective StudyNing An, Haoyi Wang, Ji Li, et al.
Pageof 78